Common Equity: The sum of all common equity items.
VistaGen Therapeutics, Inc. (VTGN) had Common Equity of $81.12M for the most recently reported fiscal quarter, ending 2024-12-31.
| Income Statement Financials | |
$0.23M |
|
$-14.09M |
|
-- |
|
$0.23M |
|
$15.35M |
|
$-15.12M |
|
$1.03M |
|
$-14.09M |
|
$-14.09M |
|
$-14.09M |
|
$-14.09M |
|
$-14.09M |
|
$-14.09M |
|
$-15.12M |
|
$-15.18M |
|
30.71M |
|
30.71M |
|
$-0.46 |
|
$-0.46 |
|
| Balance Sheet Financials | |
$89.94M |
|
$0.43M |
|
$2.37M |
|
$92.31M |
|
$9.62M |
|
-- |
|
$1.56M |
|
$11.19M |
|
|
Common Equity |
$81.12M |
$81.12M |
|
$81.12M |
|
28.32M |
|
| Cash Flow Statement Financials | |
$-32.03M |
|
$-13.68M |
|
$1.26M |
|
$119.17M |
|
$74.72M |
|
$-44.45M |
|
$3.35M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
9.35 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-6461.54% |
|
-6461.54% |
|
-- |
|
-6020.94% |
|
-6020.94% |
|
$-32.14M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
-- |
|
-- |
|
-17.37% |
|
-17.37% |
|
-15.26% |
|
-17.37% |
|
$2.86 |
|
$-1.05 |
|
$-1.04 |
|